Liver surgery with weight-loss surgery for metabolic liver cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies combining liver surgery with weight-loss surgery (sleeve gastrectomy) for people who have liver cancer caused by metabolic syndrome and also have obesity. The goal is to see if doing both procedures at once is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and willing to sign a consent form.
- You must have a type of liver cancer that is directly linked to metabolic syndrome (such as obesity, diabetes, or high blood pressure) and not to other causes like hepatitis or alcohol.
- Your liver function must be good (Child-Pugh class A).
- You must be a candidate for liver surgery using minimally invasive techniques (laparoscopic or robotic).
- You must also be eligible for weight-loss (bariatric) surgery, which includes having a high body mass index (BMI) — for example, BMI 40 or greater, or 35-39 with health problems, or 30-34 with type 2 diabetes or poorly controlled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how sleeve gastrectomy affects metabolism, digestion, and weight loss in people with severe obesity. You are eligible if you recently had surgery and are not using certain supplements.
This study tests if a procedure called endoscopic sleeve gastroplasty helps people with obesity and a liver condition called MASH lose weight and improve their liver health. It might be an option if you have both obesity and MASH and haven't had weight-loss surgery before.
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This trial tests if doing a TIPS procedure (to lower blood pressure in the liver) before weight-loss surgery (sleeve gastrectomy) helps people with advanced liver disease. It's for those who have cirrhosis and very high blood pressure in the liver, and who qualify for sleeve gastrectomy.
This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.
Hear when a new Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.